REGN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Regeneron Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 602.92 USD 0.38% Market Closed

Market Cap: $63.2B

	Regeneron Pharmaceuticals Inc NASDAQ:REGN	US
	Nissan Motor Co Ltd OTC:NSANF	JP
W	World Wrestling Entertainment Inc LSE:0M1G	US
	Enad Global 7 AB (publ) OTC:ENADF	SE
	MorphoSys AG XETRA:MOR	DE
S	Siem Offshore Inc OSE:SIOFF	NO
	Marr SpA MIL:MARR	IT
	Lovisa Holdings Ltd F:LO7	AU
	Encore Capital Group Inc NASDAQ:ECPG	US
	Corsa Coal Corp XTSX:CSO	US
E	Eurofins Scientific SE DUS:ESF0	LU
V	Vodafone Group PLC F:VODI	UK

Profitability Summary

Regeneron Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

89% > 87%

Healthy Operating Margin

27%

Strong 3Y Average Operating Margin

31%

Declining Operating Margin

40% > 27%

Exceptional Net Margin

31%

Strong 3Y Average Net Margin

32%

Declining Net Margin

34% > 31%

Exceptional Free Cash Flow Margin

26%

Strong 3Y Average Free Cash Flow Margin

26%

Free Cash Flow Margin is Increasing

20% > 26%

Positive ROE

15%

Positive 3Y Average ROE

Positive 3Y Average ROIC

17%

Declining ROIC

22% > 18%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.